Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
Por un escritor de hombre misterioso
Descripción
Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target, Experimental Hematology & Oncology
Four challenges to CAR T cells breaking the glass ceiling - Bailey - 2023 - European Journal of Immunology - Wiley Online Library
The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies, Cell & Bioscience
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy. - Abstract - Europe PMC
Bidirectional interaction between intestinal microbiome and cancer: opportunities for therapeutic interventions, Biomarker Research
Frontiers The impact of microbiome dysbiosis on T cell function within the tumor microenvironment (TME)
Frontiers Broadening the horizon: potential applications of CAR-T cells beyond current indications
Cancers, Free Full-Text
CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies
Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy - ScienceDirect
Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target, Experimental Hematology & Oncology
Frontiers Dietary fungi in cancer immunotherapy: From the perspective of gut microbiota
Exploring the food-gut axis in immunotherapy response of cancer patients
Infectious complications of CAR T-cell therapy: a clinical update - Adam G. Stewart, Andrea S. Henden, 2021
Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple Myeloma - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and
de
por adulto (el precio varía según el tamaño del grupo)